JP2015193630A5 - - Google Patents

Download PDF

Info

Publication number
JP2015193630A5
JP2015193630A5 JP2015104213A JP2015104213A JP2015193630A5 JP 2015193630 A5 JP2015193630 A5 JP 2015193630A5 JP 2015104213 A JP2015104213 A JP 2015104213A JP 2015104213 A JP2015104213 A JP 2015104213A JP 2015193630 A5 JP2015193630 A5 JP 2015193630A5
Authority
JP
Japan
Prior art keywords
sodium salt
salt dihydrate
crystalline genistein
genistein sodium
peaks
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015104213A
Other languages
English (en)
Japanese (ja)
Other versions
JP6067781B2 (ja
JP2015193630A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2015193630A publication Critical patent/JP2015193630A/ja
Publication of JP2015193630A5 publication Critical patent/JP2015193630A5/ja
Application granted granted Critical
Publication of JP6067781B2 publication Critical patent/JP6067781B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015104213A 2008-12-11 2015-05-22 ゲニステインの結晶形 Expired - Fee Related JP6067781B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US12178708P 2008-12-11 2008-12-11
US12177808P 2008-12-11 2008-12-11
US61/121,778 2008-12-11
US61/121,787 2008-12-11

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2011540919A Division JP5898958B2 (ja) 2008-12-11 2009-12-11 ゲニステインの結晶形

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016247753A Division JP2017061566A (ja) 2008-12-11 2016-12-21 ゲニステインの結晶形

Publications (3)

Publication Number Publication Date
JP2015193630A JP2015193630A (ja) 2015-11-05
JP2015193630A5 true JP2015193630A5 (enExample) 2016-01-28
JP6067781B2 JP6067781B2 (ja) 2017-01-25

Family

ID=42243089

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2011540919A Expired - Fee Related JP5898958B2 (ja) 2008-12-11 2009-12-11 ゲニステインの結晶形
JP2015104213A Expired - Fee Related JP6067781B2 (ja) 2008-12-11 2015-05-22 ゲニステインの結晶形
JP2016247753A Pending JP2017061566A (ja) 2008-12-11 2016-12-21 ゲニステインの結晶形

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2011540919A Expired - Fee Related JP5898958B2 (ja) 2008-12-11 2009-12-11 ゲニステインの結晶形

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016247753A Pending JP2017061566A (ja) 2008-12-11 2016-12-21 ゲニステインの結晶形

Country Status (11)

Country Link
US (2) US9012495B2 (enExample)
EP (1) EP2373326B1 (enExample)
JP (3) JP5898958B2 (enExample)
KR (2) KR20110106355A (enExample)
CN (2) CN102292097B (enExample)
AU (1) AU2009324489B2 (enExample)
BR (1) BRPI0923504A2 (enExample)
CA (1) CA2746652C (enExample)
IL (2) IL213473A (enExample)
WO (1) WO2010068861A1 (enExample)
ZA (1) ZA201105045B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20110106355A (ko) 2008-12-11 2011-09-28 악센투아 파마슈투칼스 아베 제니스테인의 결정성 형태
US7863325B2 (en) 2008-12-11 2011-01-04 Axcentua Pharmaceuticals Ab Crystalline genistein sodium salt dihydrate
WO2011104667A1 (en) * 2010-02-25 2011-09-01 Anthem Biosciences Private Limited Basic aminoacid salts of polyphenols
CN102442990B (zh) * 2010-10-12 2015-03-11 上海睿智化学研究有限公司 一种金雀异黄素烟酰胺共晶、其晶体及其制备方法
CN102442989B (zh) * 2010-10-12 2015-04-08 上海睿智化学研究有限公司 一种金雀异黄素盐、其晶体及其制备方法
CN102442991B (zh) * 2010-10-12 2015-03-11 上海睿智化学研究有限公司 一种金雀异黄素维生素b6共晶、其晶体及其制备方法
CN105963246B (zh) * 2016-05-06 2018-12-25 荆楚理工学院 一种染料木素盐口服溶液剂及制备方法和应用
CN105853350A (zh) * 2016-05-24 2016-08-17 荆楚理工学院 一种染料木素溶液及制备方法和应用
CN109666014A (zh) * 2018-12-12 2019-04-23 荆门医药工业技术研究院 一种染料木素衍生物盐的制备方法及其应用
US20240058298A1 (en) 2020-12-03 2024-02-22 Delta 4 Gmbh Genistein for use in the treatment of focal segmental glomerulosclerosis (fsgs)
CN119095592A (zh) 2022-04-28 2024-12-06 绿石生物科学公司 大麻素的不良心血管作用的治疗
CN122374320A (zh) 2023-11-28 2026-07-10 绿石生物科学公司 染料木素磷酸酯衍生物

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62201882A (ja) * 1985-11-18 1987-09-05 Yamanouchi Pharmaceut Co Ltd イソフラボン誘導体
JPH07506822A (ja) 1992-05-19 1995-07-27 ノボゲン　リサーチ　ピーティーワイ　リミッテッド フィト−エストロゲン，類似体またはその代謝産物を含有する健康補助剤
DE4331233A1 (de) * 1993-09-15 1995-03-16 Basf Ag Verfahren zur Herstellung von Hydroxyoxaalkylmelaminen
US5569459A (en) * 1995-02-15 1996-10-29 Bio-Virus Research Incorporated Pharmaceutical compositions for the management of premenstrual syndrome and alleviation of menopausal disorders
US5554519A (en) 1995-08-07 1996-09-10 Fermalogic, Inc. Process of preparing genistein
PL179170B1 (pl) * 1995-09-15 2000-07-31 Inst Lekow Nowe zwiazki,pochodne genisteiny PL PL PL PL
GB9624482D0 (en) 1995-12-18 1997-01-15 Zeneca Phaema S A Chemical compounds
CA2242425C (en) 1996-02-13 2006-07-18 Zeneca Limited Quinazoline derivatives as vegf inhibitors
NZ331191A (en) 1996-03-05 2000-03-27 Zeneca Ltd 4-anilinoquinazoline derivatives and pharmaceutical compositions thereof
GB9613455D0 (en) * 1996-06-27 1996-08-28 Aston Molecules Ltd Analogues or derivatives of quercetin
GB9718972D0 (en) 1996-09-25 1997-11-12 Zeneca Ltd Chemical compounds
GB9714249D0 (en) 1997-07-08 1997-09-10 Angiogene Pharm Ltd Vascular damaging agents
US5981775A (en) 1998-09-16 1999-11-09 Board Of Trustees Operating Michigan State University Process for the preparation of isoflavones
US6194469B1 (en) * 1998-12-11 2001-02-27 Board Of Trustees Operating Michigan State Univeristy Method for inhibiting cyclooxygenase and inflammation using cherry bioflavonoids
GB9900334D0 (en) 1999-01-07 1999-02-24 Angiogene Pharm Ltd Tricylic vascular damaging agents
GB9900752D0 (en) 1999-01-15 1999-03-03 Angiogene Pharm Ltd Benzimidazole vascular damaging agents
AUPQ520300A0 (en) * 2000-01-21 2000-02-17 Novogen Research Pty Ltd Food product and process
BR0111230A (pt) 2000-05-31 2003-06-10 Astrazeneca Ab Composto, e, uso e processo para a preparação do mesmo
ATE265858T1 (de) * 2000-06-16 2004-05-15 Linnea Sa Wasserlöslicher komplex eines ginkgo biloba extrakts, verfahren zu dessen herstellung und diesen enthaltende zusammensetzung
KR20030014425A (ko) 2000-07-07 2003-02-17 앤지오젠 파마슈티칼스 리미티드 혈관 손상제인 콜치놀 유도체
EE200300015A (et) 2000-07-07 2004-10-15 Angiogene Pharmaceuticals Limited Kolhinooli derivaadid kui angiogeneesi inhibiitorid
US6541613B2 (en) * 2000-12-15 2003-04-01 Uyrex Corporation Isoflavone derivatives
PL205635B1 (pl) * 2001-04-09 2010-05-31 Inst Farmaceutyczny Nowe pochodne genisteiny i zawierające je środki farmaceutyczne
CN100348592C (zh) * 2001-12-28 2007-11-14 中国人民解放军第二军医大学 3，7，8－三取代－5－羟基苯并－γ－吡喃酮类化合物及其制备方法
US20040023981A1 (en) * 2002-07-24 2004-02-05 Yu Ren Salt forms with tyrosine kinase activity
UA83814C2 (ru) 2002-12-24 2008-08-26 Астразенека Аб Производные фосфонооксихиназолина и их фармацевтическое применение
EP1765379A4 (en) * 2004-06-17 2009-05-27 Transform Pharmaceuticals Inc PHARMACEUTICAL CO-CRYSTAL COMPOSITIONS AND RELEVANT USE METHOD
ATE473737T1 (de) * 2004-07-20 2010-07-15 Furfural Espanol S A Verwendung von 2,3-dehydronaringenin-derivaten zur behandlung von entzündungsprozessen und diese derivate enthaltende pharmazeutische zusammensetzung
ES2351257T3 (es) * 2005-02-15 2011-02-02 Dsm Ip Assets B.V. Composiciones que contienen polisacáridos.
ATE520396T1 (de) * 2005-06-29 2011-09-15 Dsm Ip Assets Bv Isoflavon-nanoteilchen und ihre verwendung
EP1921916A2 (en) * 2005-08-11 2008-05-21 The Scripps Research Institute Genistein inhibition of transthyretin amyloidosis
WO2007061254A1 (en) 2005-11-25 2007-05-31 B & C Biopharm. Co., Ltd. Genistein derivatives and anti-fungal composition containing the same
WO2008034016A2 (en) * 2006-09-15 2008-03-20 Foldrx Pharmaceuticals, Inc. Assays for detecting native-state proteins and identifying compounds that modulate the stability of native-state proteins
JP2008094751A (ja) * 2006-10-11 2008-04-24 Ono Pharmaceut Co Ltd プランルカスト水和物含有医薬組成物
KR20110106355A (ko) 2008-12-11 2011-09-28 악센투아 파마슈투칼스 아베 제니스테인의 결정성 형태

Similar Documents

Publication Publication Date Title
JP2013237682A5 (enExample)
JP2017061566A5 (enExample)
HRP20250119T1 (hr) Kdm1a inhibitor i njegova primjena u terapiji
EA201592250A1 (ru) Пиразолопирролидиновые производные и их применение в лечение заболеваний
JP2016508134A5 (enExample)
EA201592256A1 (ru) Производные имидазопирролидинона и их применение при лечении заболеваний
MX2022001863A (es) Metodos para tratar los tumores del estroma gastrointestinal.
JP2017524735A5 (enExample)
PH12015501517A1 (en) Pyrimidone derivatives and their use in the treatment, amelioration or prevention of a viral disease
JP2013509429A5 (enExample)
JP2016515561A5 (enExample)
JP2012082234A5 (enExample)
IL295418B1 (en) Beta-d-2'-deoxy-2' alpha-fluoro-2'-bata-c-modified-2-different-n6-purine modified nucleotides for the treatment of hepatitis c virus
EA201691058A1 (ru) Производные пирролопирролона и их применение для лечения заболеваний
JP2016501221A5 (enExample)
TN2015000293A1 (en) Heterocycle-substituted tetracyclic compounds and methods of use thereof for treatment of viral diseases
MX2015016421A (es) Derivados de pirazolo-pirrolidin-4-ona como inhibidores de bet y su uso en el tratamiento de enfermedades.
HRP20171648T1 (hr) Supstituirani piperidil-etil-pirimidin kao inhibitor grelin-o-acil-transferaze
EA201592254A1 (ru) Производные пиразолопирролидин-4-она и их применение при лечении заболевания
JP2012512164A5 (enExample)
IL311873A (en) Combination therapy for treating malignancies
JP2015516419A5 (enExample)
NZ758449A (en) Heteroaromatic compounds useful in therapy
JP2015537009A5 (enExample)
BR112015016184A2 (pt) derivados de piridona e seu uso no tratamento, melhora ou prevenção de uma doença viral